As of Friday close, GE HealthCare Technologies Inc.’s (NASDAQ:GEHC) stock was up $0.44, moving up 0.69 percent to $64.33. The average number of shares traded per day over the past five days has been 2,523,300 shares. 1 time new highs have been achieved over the past 5 days, with a -$2.10 fall in that time frame. In the last twenty days, the average volume was 3,044,530, while in the previous 50 days, it was 3,049,710.
Since last month, GEHC stock retreated -6.75%. Shares of the company fell to $63.74 on 09/22/23, the lowest level in the past month. Since the beginning of this year, GEHC’s stock price has risen by 10.19% or $5.95, and marked a new high 25 times. However, the stock has declined by -26.76% since its 52-week high.
GEHC stock investors should be aware that GE HealthCare Technologies Inc. (GEHC) stock had its last reported insider trading activity 54 days ago on Jul 31. O’Neill Kevin Michael, the CEO, PDx of the company, disposed of 15,609 shares for $77.32 on Jul 31. It resulted in a $1,206,949 divestment by the insider. Rott Roland sold 2,473 shares at an average price of $77.37 on Jun 08. The insider now owns 22,335 shares following the transaction. On Mar 14, CEO, Imaging Makela Jan sold 70,629 shares at $77.69 apiece. The transaction was valued at $5,487,379.
Valuation Metrics
Right now, GE HealthCare Technologies Inc. (GEHC) has a P/E ratio of about 16.01. Besides these, the trailing price-to-sales (P/S) ratio of 1.53, the price-to-book (PB) ratio of 4.12, and the price-to-cash flow ratio of 17.09 may also be considered.
The latest dividend of $0.03 per share was paid out, remained unchanged from last year’s $0.03.
Financial Health
In the three months ended June 29, GE HealthCare Technologies Inc.’s quick ratio stood at 0.90, while its current ratio was 1.20, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 1.44, and the total debt-to-equity ratio was 1.44. On the profitability front, the trailing twelve-month gross margin is 39.60% percent. In the year ended June 29, EBITDA margin amounted to 17.43%, whereas operating margins totaled 13.20%. Based on annual data, GEHC earned $7.18 billion in gross profit and brought in $18.34 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 11.10%. Return on equity (ROE) for the past 12 months was 18.30%.
In GE HealthCare Technologies Inc.’s quarter-end financial report for June 29, it reported total debt of $10.23 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. GEHC’s revenue rose 100.0% to $3.93 billion during the quarter, while net income inched up to $4.02 billion. While analysts expected GE HealthCare Technologies Inc. to report $0.87 quarterly earnings, the actual figure was $0.92 per share, beating the consensus estimate by 5.70%. During the quarter, the company generated $726.0 million in EBITDA. The liabilities of GE HealthCare Technologies Inc. were 25.2 billion at the end of its most recent quarter ended June 29, and its total debt was $10.61 billion. The value of shareholders’ equity is $454.84 million.
Technical Picture
This quick technical analysis looks at GE HealthCare Technologies Inc.’s (GEHC) price momentum. With a historical volatility rate of 20.80%, the RSI 9-day stood at 33.36% on 22 September.
With respect to its five-day moving average, the current GE HealthCare Technologies Inc. price is down by -3.16% percent or -$2.10. At present, GEHC shares trade -5.99% below its 20-day simple moving average and -20.36% percent below its 100-day simple moving average. However, the stock is currently trading approximately -20.97% below its SMA50.
Stochastic coefficient K was 7.96% and Stochastic coefficient D was 14.83%, while ATR was 1.45. Given the Stochastic reading of 10.95% for the 14-day period, the RSI (14) reading has been calculated as 32.88%. As of today, the MACD Oscillator reading stands at -0.92, while the 14-day reading stands at -1.31.
Analyst Ratings
Citigroup launched its rating on GE HealthCare Technologies Inc. (NASDAQ: GEHC) to a Buy in a note to investors on September 19, 2023. GE HealthCare Technologies Inc. (GEHC) has been rated Overweight by analysts. According to 1 brokerage firm, GEHC is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 1 analyst rate GE HealthCare Technologies Inc. stock as buy, with 8 recommending it as overweight.
With a median target price of $90.00, the current consensus forecast for the stock is $78.00 – $99.00. Based on these forecasts, analysts predict GE HealthCare Technologies Inc. (GEHC) will achieve an average price target of $89.18.
